Zacks Investment Research on MSN
UiPath, Inc. (PATH) is attracting investor attention: Here is what you should know
UiPath (PATH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Investor's Business Daily on MSN
UiPath sees composite rating move up to 96
UiPath PATH saw its IBD SmartSelect Composite Rating rise to 96 Wednesday, up from 94 the day before. Please watch the video at Investors.com - Stock Market Exposure: How To Make Incremental Portfolio ...
UiPath is making significant strides in Agentic Automation, partnering with Deloitte and HCLTech to advance AI-driven solutions. UiPath's Q2 results show robust revenue and profitability, but ARR ...
PATH is transitioning from an RPA provider to a leading agent AI platform, underpinned by strategic partnerships with Snowflake, Google, Microsoft, and Nvidia. PATH possesses every capability to take ...
Specialty pharmacy organization recognized as one of the 25 most innovative UiPath customers leveraging agentic automation NEW PROVIDENCE, NJ, UNITED STATES, October ...
NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a leading enterprise automation software company, today announces the launch of UiPath Marketplace monetization, an offering designed to enable UiPath ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback